Dernières publications scientifiques

  • Genome-wide association study reveals two novel genetic loci associated with chronic lung allograft dysfunction.

  • Auteurs Brocard S, Mauduit V, Morin M, Boussamet L, Dos Santos Brito Silva N, Durand A, Halitim P, Renaud-Picard B, Coiffard B, Demant X, Falque L, Le Pavec J, Roux A, Villeneuve T, Knoop C, Merveilleux C, Salpin M, Carlier N, Gourraud PA, Magnan A, Lair D, Berthelot L, Südholt M, Vince N, Tissot A, Limou S
  • Revue J Heart Lung Transplant
  • Date de publication 2026-03
Genome-wide association study reveals two novel genetic loci associated with chronic lung allograft dysfunction.
  • Electrophysiology Consumables Procurement in Europe: Implications for Access, Innovation and Value-Based Care.

  • Auteurs Osoro L, Kozhuharov N, Landen R, Arbelo E, Martinek M, Leclerq C, Fauchier L, Deharo JC, Boveda S, Sommer P, Rienstra M, Szymanski P, Farkowski M, Costa F, Tint D, Simovic S, Dzhinsov K, Leyva F, Boriani G, Figueras J, Ihara Z, Merino JL, Burri H, Pürerfellner H, Casado-Arroyo R
  • Revue Europace
  • Date de publication 2026-03
Electrophysiology Consumables Procurement in Europe: Implications for Access, Innovation and Value-Based Care.
  • Clinical characteristics and cancer risk of anti-OJ antisynthetase syndrome: A cohort comparative study and a systematic literature review.

  • Auteurs Pillot V, Toquet S, Charuel JL, Tansley S, Boussouar S, Brillet PY, Lu H, Vellas D, Boulahfa ST, Louis SL, Uzunhan Y, Belle A, Cohen P, Ghillani-Dalbin P, Miyara M, Hie M, Foulon G, Gambier N, Boitiaux JF, Fuzibet P, Crestani B, Baudelet L, Ilzkovitz M, Nagant C, Bouvier AM, Jooste V, Benveniste O, Allenbach Y
  • Revue Autoimmun Rev
  • Date de publication 2026-03
Clinical characteristics and cancer risk of anti-OJ antisynthetase syndrome: A cohort comparative study and a systematic literature review.
  • Development of a Performance Measurement Framework for European Health Technology Assessment: Stakeholder-Centric Key Performance Indicators Identified in a Delphi Approach by the European Access Academy.

  • Auteurs Julian E, Xander NSH, Boumaki K, Garcia MJ, Jahimovica E, Mosset-Keane J, Otto MH, Pavlovic M, Scroccaro G, Strammiello V, Bernardini R, Capri S, Casado-Arroyo R, Desmet T, Van Dyck W, Fricke FU, Gianfrate F, Solà-Morales O, Wasem J, Wörmann BJ, Ruof J
  • Revue J Mark Access Health Policy
  • Date de publication 2026-03
Development of a Performance Measurement Framework for European Health Technology Assessment: Stakeholder-Centric Key Performance Indicators Identified in a Delphi Approach by the European Access Academy.
  • Understanding the patient journey: Barriers, facilitators, and expectations in joining a chemotherapy de-escalation trial among premenopausal patients with breast cancer.

  • Auteurs Zyumbileva P, Spanic T, Gillanders E, Martin E, Zambon M, Connolly M, Dutarte M, Tricanico E, Caballero C, El-Abed S, Dunn J, Merckaert I, Macpherson IR, Vanhecke A, Vaz-Luis I, Franzoi MA
  • Revue Breast
  • Date de publication 2026-03
Understanding the patient journey: Barriers, facilitators, and expectations in joining a chemotherapy de-escalation trial among premenopausal patients with breast cancer.
  • Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial.

  • Auteurs Ogbogu PU, Roufosse F, Akuthota P, Kuna P, Groh M, Reiter A, Yokota A, Siddiqui SH, Mutsaers PGNJ, Li B, Khoury P, Bahadori LM, Bednarczyk A, Bouma G, Brooks LG, Ferreira J, Grindebacke H, Ho CN, Jain P, Palmer RL, Jison ML, Klion AD
  • Revue Nat Med
  • Date de publication 2026-03
Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial.
Bordet hospital

Institut Jules Bordet

Consultez toutes les publications scientifiques de Jules Bordet

Erasme hospital

Hôpital Erasme

Consultez toutes les publications scientifiques d'Erasme

Huderf hospital

Hôpital pédiatrique Reine Fabiola

Voir toutes les publications scientifiques de l'Hôpital pédiatrique Reine Fabiola